472 related articles for article (PubMed ID: 16226443)
21. Association of the asthma control questionnaire with exercise-induced bronchoconstriction.
Madhuban AA; Driessen JM; Brusse-Keizer MG; van Aalderen WM; de Jongh FH; Thio BJ
J Asthma; 2011 Apr; 48(3):275-8. PubMed ID: 21348805
[TBL] [Abstract][Full Text] [Related]
22. [Asthma control level in asthmatic children followed in general practice medicine in France: results of ER'ASTHME study].
de Blic J; Boucot I; Pribil C; Huas D; Godard P
Arch Pediatr; 2007 Sep; 14(9):1069-75. PubMed ID: 17566720
[TBL] [Abstract][Full Text] [Related]
23. Asthma control and management: a patient's perspective.
Manning P; Greally P; Shanahan E
Ir Med J; 2005; 98(10):231-2, 234-5. PubMed ID: 16445140
[TBL] [Abstract][Full Text] [Related]
24. Patients' experience of asthma control and clinical guidelines: perspectives from a qualitative study.
Rudell K; Hareendran A; Bonner N; Arbuckle R; Burbridge C; Abetz L
Respir Med; 2012 Jun; 106(6):909-11. PubMed ID: 22361503
[TBL] [Abstract][Full Text] [Related]
25. Control of persistent asthma in Spain: associated factors.
Díez Jde M; Barcina C; Muñoz M; Leal M
J Asthma; 2008 Nov; 45(9):740-6. PubMed ID: 18972288
[TBL] [Abstract][Full Text] [Related]
26. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data.
Schatz M; Zeiger RS; Vollmer WM; Mosen D; Apter AJ; Stibolt TB; Leong A; Johnson MS; Mendoza G; Cook EF
J Allergy Clin Immunol; 2006 May; 117(5):995-1000. PubMed ID: 16675324
[TBL] [Abstract][Full Text] [Related]
27. Disease impact and patient insight--a study on a local population of asthmatics.
Ahmad NS; Chan MY; Hiew FL; Sharif SA; Vijayasingham P; Thayaparan T; Loh LC
Med J Malaysia; 2003 Oct; 58(4):526-32. PubMed ID: 15190628
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in asthmatic outpatients.
Almada Lobo F; Almada-Lobo B
J Asthma; 2008; 45(1):27-32. PubMed ID: 18259992
[TBL] [Abstract][Full Text] [Related]
29. Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study.
Mehuys E; Van Bortel L; Annemans L; Remon JP; Van Tongelen I; Van Ganse E; Laforest L; Chamba G; Brusselle G
Respir Med; 2006 Aug; 100(8):1407-14. PubMed ID: 16386885
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of asthma control using Global Initiative for Asthma criteria and the Asthma Control Test in Uganda.
Serugendo AN; Kirenga BJ; Hawkes M; Nakiyingi L; Worodria W; Okot-Nwang M
Int J Tuberc Lung Dis; 2014 Mar; 18(3):371-6. PubMed ID: 24670578
[TBL] [Abstract][Full Text] [Related]
31. Concordance between supervised and postal administration of the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) and Asthma Control Questionnaire (ACQ) was very high.
Pinnock H; Juniper EF; Sheikh A
J Clin Epidemiol; 2005 Aug; 58(8):809-14. PubMed ID: 16018916
[TBL] [Abstract][Full Text] [Related]
32. Sleep quality in asthma: results of a large prospective clinical trial.
Mastronarde JG; Wise RA; Shade DM; Olopade CO; Scharf SM;
J Asthma; 2008 Apr; 45(3):183-9. PubMed ID: 18415823
[TBL] [Abstract][Full Text] [Related]
33. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma.
Humbert M; Berger W; Rapatz G; Turk F
Allergy; 2008 May; 63(5):592-6. PubMed ID: 18355388
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
35. Asthma control and compliance in a cohort of adult asthmatics: first survey in Israel.
Starobin D; Bargutin M; Rosenberg I; Yarmolovsky A; Levi T; Fink G
Isr Med Assoc J; 2007 May; 9(5):358-60. PubMed ID: 17591372
[TBL] [Abstract][Full Text] [Related]
36. The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study.
Sthoeger ZM; Eliraz A; Asher I; Berkman N; Elbirt D
Isr Med Assoc J; 2007 Jun; 9(6):472-5. PubMed ID: 17642399
[TBL] [Abstract][Full Text] [Related]
37. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment.
Peters SP; Ferguson G; Deniz Y; Reisner C
Respir Med; 2006 Jul; 100(7):1139-51. PubMed ID: 16713224
[TBL] [Abstract][Full Text] [Related]
38. Quality of asthma care: results from a community pharmacy based survey.
Laforest L; Van Ganse E; Devouassoux G; Chretin S; Bauguil G; Pacheco Y; Chamba G
Allergy; 2005 Dec; 60(12):1505-10. PubMed ID: 16266382
[TBL] [Abstract][Full Text] [Related]
39. [Influence of education level on self-evaluation and control of patients with bronchial asthma].
Zhao HJ; Cai SX; Tong WC; Li WJ; Fu L
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):715-7. PubMed ID: 18504187
[TBL] [Abstract][Full Text] [Related]
40. Symptom control and improved functioning: the effect of omalizumab on asthma-related quality of life (ARQL).
Luskin AT; Kosinski M; Bresnahan BW; Ashby M; Wong DA
J Asthma; 2005 Dec; 42(10):823-7. PubMed ID: 16393718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
